Large, well conducted clinical trials are needed urgently to support guidelines on prevention and clinical management. Open collaboration and data sharing in these trials must be mandated while protecting the rights of participants and patients. This includes research undertaken by the private sector. The article supports the WHO’s efforts to counter the COVID-19 pandemic. [Link to PDF on the right]
Also By
ISARIC
- Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
- What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? - A harmonised, global longitudinal observational study
- An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a rando
Please Sign in (or Register) to view further.